Bioventus, Inc. (BVS)
Bioventus Market Cap : 591.41M for April 2, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Abbott Laboratories | 179.61B |
| Accuray, Inc. | 52.27M |
| Alphatec Holdings, Inc. | 1.577B |
| Boston Scientific Corp. | 94.45B |
| Plus Therapeutics, Inc. | 22.33M |
Market Cap Related Metrics
| PE Ratio | 26.80 |
| PS Ratio | 1.053 |
| Price to Book Value | 3.212 |
| Price to Free Cash Flow | 8.379 |
| Price | 8.97 |
| Earnings Yield | 3.73% |
| Operating PE Ratio | 10.42 |
| Normalized PE Ratio | 24.12 |